Gavin Xia

Inga fler pågående positioner

Förmögenhet: 114 M $ per 2026-05-31

47 år

98 relationer

Health Technology

Consumer Services

Finance

Profil

Dr. Gavin Xia is a Chief Executive Officer at Alebund Pharmaceuticals (Jiangsu) Ltd., a Chief Executive Officer at Shanghai Alebund Pharmaceutical Technology Co., Ltd. and a Venture Partner at LAV Management Co., Ltd. Dr. Xia was previously employed as a Non-Executive Director by Abbisko Cayman Ltd. and a Non-Executive Director by Abbisko Therapeutics Co., Ltd. He also served on the board at Shanghai Kun Yuan Biotechnology Co. Ltd. and Beijing Jiakesi New Drug Development Co. Ltd. He received his undergraduate degree from Peking University and a doctorate degree from The University of Chicago.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
8,54 %	2026-06-29	19 401 461 ( 8,54 % )	114 M $	2026-05-31
11,33 %	2026-06-29	32 069 014 ( 11,33 % )	321 $	2026-05-31

Aktiva positioner av Gavin Xia

Företag	Position	Start
LAV Management Co., Ltd. LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements.	Privat kapitalinvesterare	-
Shanghai Alebund Pharmaceutical Technology Co., Ltd. Shanghai Alebund Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company, focuses on novel therapies discovery and development for kidney diseases	Verkställande Direktör	-

Alla aktiva positioner av Gavin Xia

Tidigare kända positioner av Gavin Xia

Företag	Position	Slut
ABBISKO CAYMAN LIMITED	Direktör/Styrelseledamot	2023-06-19
Shanghai Kun Yuan Biotechnology Co. Ltd.	Direktör/Styrelseledamot	2021-02-01
Beijing Jiakesi New Drug Development Co. Ltd. Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells drugs	Direktör/Styrelseledamot	-
Abbisko Therapeutics Co., Ltd. Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology	Direktör/Styrelseledamot	-

Se detaljerna i Gavin Xias erfarenhet

Gavin Xias utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Gavin Xias erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	8
Peking University Peking University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Chicago The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LAV Management Co., Ltd. LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements.	Finance
Abbisko Therapeutics Co., Ltd. Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Researches and develops biomedicine and biotechnology	Health Technology
Beijing Jiakesi New Drug Development Co. Ltd. Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and sells drugs	Health Technology
Shanghai Alebund Pharmaceutical Technology Co., Ltd. Shanghai Alebund Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company, focuses on novel therapies discovery and development for kidney diseases	Health Technology
Abbisko Cayman Ltd. Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies	Health Technology
Shanghai Kun Yuan Biotechnology Co. Ltd.